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Abstract 
A common limitation of using polymeric micro- and nanoparticles in long-term conservation is due to 
their poor physical and chemical stability. Freeze-drying is one of the most convenient methods that 
enable further reconstitution of micro- and nanoparticles for therapeutical use. Nevertheless, this 
process generates various stresses during freezing and desiccation steps. This paper underlines the 
combined outcomes of freeze drying method and physicochemical solvent/non-solvent approach to 
design biocompatible poly(epsilon-caprolactone) (PCL) nanospheres and evaluate influence of 
different cryoprotectants (glucose, saccharose, polyvinyl alcohol or polyglutamic acid) on the outcome 
of freeze-dried PCL particles. Samples were characterized using Fourier transform infrared 
spectroscopy (FT-IR), scanning electron microscopy (SEM) and dynamic light scattering method 
(DLS). In vitro studies used, include MTT assay (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide), testing cytotoxicity as the quality of being toxic to cells, and DCFH-
DA assay (2’,7’-dichlordihydrofluorescein-diacetate), testing the possible increase in ROS levels. It 
was found that cryoprotection with 1% glucose solution is an optimal for obtaining uniform, spherical 
but also biocompatible PCL nanoparticles for biomedical purposes. 
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1. Introduction 
During the last few decades, extensive work has been done to develop biodegradable polymers 
suitable for drug delivery studies and tissue engineering. 1, 2 In this way, most of the formulations, 
based on the incorporation of drugs to multiparticulate systems such as micro- or nanospheres, were 
prepared from aliphatic polyesters, such as poly(ε-caprolactone) (PCL), to ensure a specific drug 
targeting, by both the oral route and the parenteral route. 3-6 PCL, one of the most popular synthetic 
polymers, has been extensively investigated for applications as implantable or injectable 
biodegradable carrier for the controlled release of bioactive agents. 7 - 9 PCL is suitable for controlled 
drug delivery due to a high permeability to many drugs, excellent biocompatibility and its ability to be 
fully excreted from the body, once bioresorbed. 9 Biodegradation of PCL, compared to many other 
resorbable polymers, is slow, making it much more suitable for long-term degradation applications. 
PCL micro- and nanoparticles are promising drug delivery systems with obvious advantages, such as 
improving the overall therapeutic efficiency, prolonging biological activity, controlling the drug 
release rate and decreasing the administration frequency. Without occluding needles and capillaries, 
the size of nanospheres allows them to be administered intravenously via injection, unlike many other 
colloidal systems. However, the extensive application of micro- and nanospheres might be limited due 
to problems in maintaining the integrity of the liquid suspension for prolonged time period. 10 Besides 
the nontoxic properties and biodegradability, sufficient chemical and physical stability are crucial 
requirements for their industrial development. 11, 12 Freeze drying, also termed lyophilisation, is a 
process used to convert solutions of formulations into solids of sufficient stability for distribution and 
storage. This technique is a good method for conserving the integrity of particulate systems. 13, 14 
However, freeze-drying is a complex process involving changes in temperature and therefore physical 
state of materials, as well as concentrations of different substances in the liquid environment, which 
all easily disturb the stability of nanoparticle dispersion. 15 Various stresses are generated during the 
process. Some of the stresses include freezing, desiccation and mechanical stresses. For example, the 
crystallization of ice exercises mechanical stress on nanoparticles leading to their destabilization. 
Also, too high concentration of particles in dispersion may induce their aggregation and irreversible 
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fusion. Based on the literature, a number of components of the particles formulation, such as the type 
and concentration of cryoprotectant, the nature of surfactant, the chemical groups attached to the 
particles surface etc, may have significant influence on the resistance of particles to the different 
stresses during freeze-drying.15-17 To protect nanoparticles from stresses and subsequent 
agglomeration, a cryoprotectant or lyoprotectant is generally used. 16, 17 The selection of a proper 
cryoprotectant is not straightforward. In some cases, increasing cryoprotectant concentration to a 
certain level can lead to destabilization of particulate systems. 15 Depending on the system of micro- 
and nanoparticles, freeze drying conditions and the characteristics of a cryoprotectant (thermal 
properties primarily), performance of the substance to decrease agglomeration can be erratic. 
Therefore, the type of a cryoprotectant must be wisely selected and its concentration must be 
optimized in order to ensure a maximum stabilization of nanoparticles. 
 The aim of this study was to produce PCL spherical particles, by physicochemical solvent/non-
solvent method, and to evaluate influence of different cryoprotective excipients during freeze drying 
process. Sugars, such as glucose and saccharose, and polymers (polyvinyl alcohol (PVA) and 
polyglutamic acid (PGA)), were added to the formulation to test the effects on the outcome of freeze-
dried poly(ε-caprolactone) micro- and nanospheres. 
 To date, the literature has described the synthesis of PCL materials using an electrospinning, 18, 19 
dip-coating, 20 ring-opening copolymerization, 21, 22 solvent casting and melt blending methods. 23 
These have provided materials in the forms of films, scaffolds, fibers, grafts or micron-sized particles. 
The literature has also describes the obtaining of camptothecin loaded PCL nanofibrous mats through 
one-step sol–gel electrospinning process, 24 as well as the obtaining of PCL-based films co-loaded 
with 5-fluorouracil. 20 Our study thus reports on obtaining PCL nanospheres which represent an 
important system in the field of medicine, pharmacy and controlled drug delivery.  
 Samples were characterized using Fourier Transform Infrared Spectroscopy (FT-IR), Scanning 
Electron Microscopy (SEM) and Dynamic Light Scattering method (DLS). In vitro studies used 
include MTT assay, testing cytotoxicity as the quality of being toxic to cells, and DCFH-DA assay, 
testing the possible increase in ROS levels, which may result in significant damage to cell structures 
and oxidative stress. 
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2. Materials and Methods 
2.1. Materials 
Poly(ε-caprolactone) used in experiments was obtained from Lactel Absorbable Polymers 
(Birmingham, Alabama, USA) with average Mw of 50 kDa and intrinsic viscosity of 0.85 dL/g. 
Poly(L-glutamic acid) (PGA) with Mw = 20–40 kDa (99.9% HPLC purity) was purchased from 
Guilin Peptide Technology Limited (China). Saccharose was a product from VWR BDH Prolabo, 
Belgium, while glucose, PVA, chloroform and ethanol were purchased from Superlab, Serbia. All 
reagents were of the analytic grade and were used as received without further purification. The 
following agents and chemicals used for the determination of cytotoxicity and the formation of ROS 
were obtained from Sigma Aldrich (St. Louis, USA): Eagle’s Minimal Essential Medium, 
penicillin/streptomycin, L-glutamine, phosphate-buffered saline, trypsin, fetal bovine serum, non-
essential amino-acid solution (100x), MTT, dimethyl sulfoxide, tert-butyl hydroperoxide and 2,7-
dichlorofluorescein diacetate (DCFH-DA). 
2.1.1. Cell culture 
HepG2 cells were obtained from European Collection of Cell Cultures (ECACC). Cells were grown in 
Eagle Minimal Essential Medium containing 10 % fetal bovine serum, 1 % non-essential amino acid 
solution, 2 mM L-glutamine and 100 U/ml penicillin plus 100 µg/ml streptomycin at 37°C in 
humidified atmosphere and 5 % CO2. 
2.2. Freeze drying preparation of PCL particles without and with different cryoprotectants 
PCL micro- and nanospheres were synthesized using physicochemical solvent/non-solvent method. 
300 mg commercial granules of poly(ε-caprolactone) have been dissolved in 5 mL of organic solvent 
(chloroform). After approximately 1h, ethanol (20 mL) has been rapidly added into the solvent 
mixture, followed by homogenisation on magnetic stirrer (500 rpm). At that instant, after the diffusion 
of solvent into non-slovent, PCL precipitates and the solution becomes whitish. 
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2.2.1. Selection of different cryoprotectants 
PVA and PGA are commonly used as stabilizers. PVA is well known for its ability to form thin films. 
PGA is a highly anionic polymer, and with pH above its pK, carboxyl group is deprotonized, leaving 
negatively charged side chain of this polyelectrolyte. In this study, PVA and PGA will be evaluated 
for their ability to act as cryoprotectants. Carbohydrates are favoured as excipients because they can 
be easily vitrified during freezing. All excipients used are chemically innocuous.  
 5 mL of 1% water solution of saccharose, poly(vinyl alcohol), poly(L-glutamic acid) or glucose was 
added to the formulation dropwise. The obtained suspensions were then homogenized on magnetic 
stirrer for less than 1 min at 500 rpm, and subsequently poured into a petri dish and put into the freezer 
overnight. 
2.2.2. Freeze drying 
After the freezing, method of lyophilisation was utilized at -55°C and the pressure of 0.3 mbar. Main 
drying was performed for 8.5 hours, and final drying for 30 minutes, using Freeze Dryer Christ Alpha 
1-2/ LD plus. 
2.3. Fourier transform infrared spectroscopy (FTIR) 
FTIR measurements of the samples were carried out to identify the possible interactions between PCL 
and different cryoprotectants (PGA, PVA, glucose or sacharose), in terms of disrupting or creating 
new chemical bonds in the polymer structure. FTIR spectra of the samples were recorded in the range 
of 400–4000 cm-1 using a Carl Zeiss SPECORD 75 Spectrometer at 4 cm-1 resolution, using KBr 
pellet method.  
2.4. Scanning electron microscopy (SEM) 
Morphology imaging was realized using scanning electron microscope ЈЕОL-JSM-646OLV, Japan. 
The energy of electrons was 10 to 50 KeV. The samples were coated with gold for conductivity 
improvements, using physical vapour deposition technique on 3∆L-TEC SCD005 (Baltec SCD 005 
sputter coater) - 30 nA current from a distance of 50 mm, during 180 s. 
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2.5. Particle size distribution (DLS) 
The size distribution of PCL particles was determined by PSA Mastersizer2000 (Malvern Instruments 
Ltd., UK). The size measurement range of this instrument is from 20 nm up to 2 mm. For the particle 
size measurements the powder was deagglomerated in an ultrasonic bath (frequency 40 kHz and 
power 50 W) for 15 min. 
2.6. MTT Assay 
The cytotoxicity study was realized using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), according to Mossman et al. 25, with minor modifications. 26 Basis of this assay is the 
ability of dehydrogenase enzymes of intact mitochondria in living cells, to reduce MTT to insoluble 
formazan. The HepG2 cells were seeded onto 96-well microplates (Nunc, Naperville IL, USA) at a 
density of 40 000 cells/ml and incubated for 20 hours at 37°C to attach. The medium was then 
replaced by fresh complete medium containing 0, 0.0001, 0.001, 0.01, 0.1 and 1 % (v/v) of samples 
(PCL without cryoprotectants, PCL with 1% PGA and PCL with 1% glucose), and incubated for 24 h. 
In each experiment, a negative control (non-treated cells) and vehicle control (1% emulsion) was 
included. MTT (final concentration 0.5 mg/ml) was then added, incubated for an additional 3 hours, 
the medium with MTT was then removed and the formed formazan crystals dissolved in DMSO. The 
optical density (OD) was measured at 570 nm (reference filter 690 nm) using a microplate reading 
spectrofluorimeter (Synergy MX, Biotek, USA). Viability was determined by comparing the OD of 
the wells containing the treated cells with those of the non-treated cells. Five replicates per 
concentration point and three independent experiments were performed. 
 Statistical significance between treated groups and controls was determined by two tailed Student’s 
t-test and P<0.05 was considered as statistically significant. Three independent experiments with five 
replicates were performed. 
 
2.7. Determining intracellular reactive oxygen species formation – DCFH-DA assay 
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The formation of intracellular reactive oxygen species (ROS) was measured spectrophotometrically 
using a fluorescent probe, DCFH-DA as described by Osseni et al. 27, with minor modifications. 28 
DCFH-DA readily diffuses through the cell membrane and is hydrolyzed by intracellular esterases to 
non-fluorescent 2′,7′-dichlorofluorescin. In the presence of intracellular ROS it is then rapidly 
oxidized to highly fluorescent 2′,7′-dichlorofluorescein. The DCF fluorescence intensity is 
proportional to the amount of reactive oxygen species formed intracellularly.  
 HepG2 cells were seeded at a density of 75 000 cells/ml into 96-well, black, tissue culture treated 
microtiter plates (Nunc, Naperville IL, USA) in five replicates. The cells were incubated for 20 h at 
37°C in 5 % CO2 to attach, then 20 µM DCFH-DA was added for 30 min, the excess of DCFH-DA 
was then removed, and cells were treated with 0, 0.0001, 0.001, 0.01, 0.1 and 1 % v/v of samples 
(PCL without cryoprotectants, PCL with 1% PGA and PCL with 1% glucose) in PBS. Negative 
control (non-treated cells), vehicle control (1% emulsion) and positive control (0.5 mM t-BOOH) 
were included in each experiment. For the kinetic analyses the plates were maintained at 37°C and the 
fluorescence intensity was determined every 30 min during the 5 h incubation using a microplate 
reading spectrofluorimeter (Tecan, Genios, Austria) at the excitation wavelength of 485 nm and the 
emission wavelength of 530 nm.  
 Statistical significance between treated groups and controls was determined by two tailed Student’s 
t-test and by Kruskal-Wallis one-way analysis of variance (ANOVA) with Dunett's posttest; P<0.05 
was considered as statistically significant. Three independent experiments with five replicates were 
performed. 
3. Results and discussion 
3.1. Results 
3.1.1. Fourier transform infrared spectroscopy  
The infrared spectra of the PCL polymer (Figure 1) show bands characteristic for ester carbonyl (C = 
O) stretching at 1730 cm−1. High intensity peaks at 1160 cm−1, 1180 cm−1 and 1235 cm−1 represent 
carboxyl group vibrations (O = C - O). Higher intensity of mentioned bands, compared to others in 
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spectra, can be explained by the fact that those groups are more polar than others. In the part of spectra 
with higher wavenumbers, doublet can be observed at 2910 cm−1 and 2925 cm−1, representing coupled 
sp3 hybridized (C - H) symmetrical and asymmetrical bands. Asymmetrical CH2 stretching band is on 
the spectra at 2855 cm−1. Peaks on 1100 cm−1, 1040 cm−1 and 955 cm−1 are due to (C - O) bond 
vibrations, while other peaks below 900 cm−1 are from deformational (C - H) vibrations.  
 Infrared spectra are often sensitive on conformation change and ordering of molecular chains in 
semi-crystalline polymers, and this ability enables them to be used for crystallinity characterization. 
(C - O) and (C - C) bonds, characteristic for crystalline state, absorb at 1360 cm−1 and 1290 cm−1, 
while band at 1160 cm−1 represents amorphous state of the polymer. Those bands are expected since 
PCL is a semi-crystalline polymer. CH2 deformational bands showed peaks at 1460 cm−1, 1410 cm−1 
and 1390 cm−1. Wide band at 3425 cm−1 is a result of combination of (C = O) overtone and hydrogen 
bonded OH vibrations. Latter bond is very helpful in determining the residual water, as well as the 
presence of hydrogen bonds. On Figure 1a, of PCL lyophilized without cryoprotection, it can be 
observed that this bond is of very low intensity. That is also the case for PCL lyophilized with 1% 
PGA solution (Figure 1c). Other samples (Figure 1b, 1d and 1e) induced higher intensity of OH 
vibration bands. On the spectra of PCL lyophilized with 1% saccharose solution (Figure 1b), bands are 
shifted to lower wavenumbers for approximately 10 cm−1, compared to the spectra of PCL lyophilized 
without the cryoprotectant. Also, band and intensity changes below 1200 cm−1 clearly indicate to 
residual saccharose in the sample. When PCL is lyophilized with 1% PGA solution, FTIR spectrum 
shows the presence of both polymers with carbonyl bond peaks at 1730 cm−1 and 1710 cm−1 (Figure 
1c). Bands below 1200 cm−1 are different then the ones in Figure 1a and are characteristic for PGA. 
The same can be said for the spectra on Figures 1d and 1e, where lower wavenumber bands represent 
vinyl groups of residual PVA and deformational (C - C - O + C - C - H) groups of glucose, 
respectively. 
 
3.1.2. Scanning electron microscopy 
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Figure 2 shows SEM images of PCL lyophilized without and with different protective excipients. If no 
protection is present, it can be seen that after lyophilisation (Figure 2A), particles became massively 
agglomerated and deformed. Once those images were made, necessity for using cryoprotectants to 
maintain the integrity of particles was clear. Particles have irregular shapes, and sporadic spheres are 
present. With the addition of 1% saccharose solution as cryoprotectant into PCL formulation, quite 
agglomerated cuboid particles have been formed (Figure 2B). In the case of samples obtained with the 
addition of 1% PGA solution (Figure 2C), spheroidal particles with less agglomeration, compared to 
previous samples, were obtained. Apart from spheroids, there are also irregular shapes present. Figure 
2D shows SEM image of PCL lyophilized with 1% PVA solution. A continuous film of PVA can be 
observed. This film prevents the observation of individual PCL particles that reside within it. This 
polymer is one of the most frequently used stabilizers to produce stable nanoparticles. When it comes 
to PCL polymer, at this concentration, it is not very helpful. If 1% glucose solution is added to the 
system, SEM images show an obvious uniformity improvement and quite smaller spherical particles 
compared to all other samples. Particles are less than one micron, smooth surfaced and non-
agglomerated (Figure 2E).  
 In order to confirm i.e. to determine the influence of the lyophilization conditions on morphology of 
PCL particles prepared with 1% glucose solution, new sample was synthesized. Instead of freeze 
drying, sample was dried at room temperature and atmospheric pressure for 72 hours. The SEM 
images obtained for this sample are shown in Figure 3. Assuming that all other parameters of particle 
preparation were strictly controlled, it is obvious that drying temperature and pressure had substantial 
effects on particles morphology. Without liophilization, PCL particles, prepared with 1% glucose 
solution and by drying at room temperature, were micron-sized. From the SEM images (Figure 3) it 
can be seen that particles have both spherical and irregular shapes and are as well significantly 
agglomerated.  
 
3.1.3. Particle size distribution  
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Due to size and uniformity improvements with the addition of 1% glucose solution, size distribution 
profile was determined for this particular sample (Figure 4). Dynamic Light Scattering method was 
used to generate size distribution profile (Figure 4B). Results show that 10% of the number of 
particles is with 362 nm diameter, 50% of particles have diameter less than 520 nm, while 90% of 
particles are with diameter below 961 nm. Fitting parameter of 1.074% shows good correspondence of 
calculated with experimental data. 
3.1.4. MTT Assay 
Cytotoxicity of the samples was determined by MTT assay, testing 0, 0.0001, 0.001, 0.01, 0.1 and 1 % 
(v/v) concentrated samples of PCL without cryoprotectants, PCL with 1% PGA or PCL with 1% 
glucose, exposing HepG2 cells with them for 24 h (Figure 5). Samples PCL without cryoprotectants 
and PCL with 1% PGA did not significantly reduce the viability of HepG2 cells (Figure 5), while PCL 
with 1% glucose caused slight decrease in cell viability at 1 % (Figure 5). 
3.1.5. DCFH-DA Assay 
The HepG2 cells were pre-treated with DCFH-DA (20 µM) for 30 min, washed and then exposed to 
different concentrations of samples (PCL without cryoprotectants, PCL with 1% PGA, and PCL with 
1% glucose) or 0.5 mM t-BOOH as the positive control (PC). DCF fluorescence intensity was 
measured at 30 min intervals during the 5 h incubation. Sample of PCL without cryoprotectants at 
concentrations 0.1 and 1 % caused significant increase in DCF fluorescence intensity, which was after 
5 hour exposure more than two fold higher from that in control cells (Figure 6), while sample of PCL 
with 1% PGA solution did not significantly alter DCF fluorescence intensity (Figure 6). Sample of 
PCL with 1% glucose solution induced timely dependent increase in ROS levels for concentration of 
1% (v/v). 
3.2. Discussion 
In the studies of the effect of spherical carriers' size on their circulation half-life, it is often showed 
that when spherical structures reside within the range of 20 nm - 1 µm, all of the clearance 
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mechanisms are minimized and circulation times are enhanced. 29 Most current nanoparticulate 
systems are spherical in shape, and extensive work has been dedicated to studying their biological 
behaviour in vitro and in vivo. Similar to size, shape is a fundamental property of micro- and 
nanoparticles that is critically important for their intended biological functions. 
 Physicochemical solvent/non-solvent method is the starting point of this study. This method is based 
on the solvent (chloroform) diffusion into non-solvent (ethanol). Presence of ethanol results in a 
quicker precipitation and phase separation of the PCL polymer, during the diffusion of chloroform. 
After the solvent evaporation and partial freezing in the freezer, process of freeze drying has been 
utilised. During the lyophilisation, only three parameters can be controlled: shelves and condenser 
temperatures, chamber pressure and time. The most important parameter, product temperature, can not 
be directly controlled. During freezing step, system temperature was maintained at -55°C, which is 
above the glass transition temperature of PCL, but below the one of cryoprotectants. 
 Freeze drying process generates various structural modifications of the material. PCL particles 
freeze dried with no cryoprotection showed erratic morphology with obvious agglomeration (Figure 
2A), due to instability of suspended particles and the solvent evaporation. With the addition of PVA, 
PGA, glucose or saccharose, different processes occur within the formulation. 
 
3.2.1. Evaluation of saccharose, PGA, PVA and glucose as different cryoprotectants 
The order of crystallinity depends on the rate of cooling, but also on the polymer chain configuration. 
Nucleation starts at small, nanometer sized places with preferential organization of polymer chains or 
their segments. Apart from thermal mechanisms, the addition of impurities can also cause nucleation, 
which is then termed heterogeneous nucleation. In the case of lyophilized PCL with the addition of 
1% saccharose solution, saccharose may have had an effect on the crystallisation of PCL (Figure 2B). 
Saccharose does not precipitate as a crystal phase, but it becomes supersaturated when cooled below 
eutectic point. 30 This means that saccharose is highly viscous in the system, so it may have induced 
nucleation of PCL polymer by steric effects of its double ring. From a diluted solution, crystals can 
grow in lamellar, layered structures up to 10 µm long. Those structures are often observed as 
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multilayer structures. 31 Following crystallisation, ordered structures grow so that layers are stacked in 
lateral dimension. FTIR analysis (Figure 1b) shows increase in intensity of OH vibration bands, 
suggesting the presence of residual water and hydrogen bonding. 
 Poly(glutamic acid) is an anionic, hydrophobic, non-toxic and biocompatible biopolymer with 
glutamic acid in a repeating unit. Under certain circumstances, carboxylic groups of PGA are 
deprotonated, making it polyelectrolyte. SEM micrographs (Figure 2C) of PCL lyophilized with 1% 
PGA solution show spheroid particles with sizes above one micron and with irregular shapes. 
Cryoprotection by PGA can be explained with electrostatic repulsion of double electric layers. 
Potential energy of particle-particle interaction is a sum of repulsion potential that arises from electric 
double layer interactions and attraction potential from Van der Waals forces. FTIR spectra of PCL 
polymer lyophilized with 1% PGA solution shows, apart from residual PGA, that hydrogen bonds are 
relatively absent from the system. 
 In the presence of water, PVA generates film. 32, 33 From SEM micrographs, a continuous film can 
be observed (Figure 2D). This thin PVA film is not allowing the observation of individual particles 
that reside within it. During nanoparticle preparation, interpenetration of PVA and PCL molecules 
occurs. Hydrophobic vinyl segments of partially hydrolyzed PVA penetrate into PCL molecules, once 
molecules of ethanol diffuse. In addition to this, there is a high intensity peak at 3440 cm-1, in FTIR 
spectra of PCL lyophilized with 1% PVA solution. Relative sharpness of this peak suggests the 
presence of intra- and intermolecular hydrogen bonding networks. 
 Considering the ability to preserve the integrity of PCL particles from the aspect of lyophilisation, 
the best results are obtained using 1% solution of glucose. Good cryoprotective results could be 
explained by three widely suggested hypotheses. 34 - 36 Introducing it to the solution, glucose generates 
hydrogen bond networks between its hydroxyl groups and the carbonyl groups of the PCL polymer 
segments on the particle's surface. Also, water takes place in this type of bonding. With progressive 
lowering of the temperature, phase separation emerges. PCL particles, surrounded with glucose 
molecules, are being separated into a highly viscous unfrozen fraction, pulling a certain amount of 
water molecules in it. This enables better mechanical protection of PCL particles. Reaching T'g, 
glucose experiences a glass transformation, isolating PCL particles within its glassy matrix. Unfrozen 
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water acts as a plasticiser, reducing crystal pressure and preventing subsequent agglomeration. In 
addition, multi-hydroxyl components are able to maintain a spatial orientation and distance between 
individual particles after the sublimation of ice. FTIR spectra show a very high level of hydrogen 
bonding and the presence of OH bonds. 
 
3.2.2. In vitro studies 
The aim of this study was also to inspect the potential toxicity of PCL particles, lyophilised with 
different cryoprotectants or without any. Even though in vitro studies are not a complete replacement 
for animal models, using simple models provides insight to general toxicity mechanisms and can be a 
basis for further analysis. 
 Mitochondrial redox activity of HepG2 liver cells to reduce MTT to formazan was investigated, 
after treating with different samples of PCL polymer. In this test, only live cells can generate a strong 
signal, while dead cells are inactive and unable to produce any signal. Samples of PCL without 
cryoprotectant and PCL with 1% PGA did not significantly reduce the viability of HepG2 cells 
(Figure 5), while PCL with 1% glucose caused minor damage to cells at 1 % sample concentration 
(Figure 5). 
 Investigating toxicity profile, it is not always clear how particles behave in the exposed 
environment. Do cells internalize particles through endocytosis and by which mechanisms, are just 
few of many problems that need to be addressed. Apart from size, shape also has a crucial effect on 
cell adhesion and overall interaction. It has been shown that particles with different shapes undergo 
different types of endocytosis. The same case is with particles of different sizes, showing that 
spherical particles of 200 nm diameter are internalized by clathrin mediated endocytosis, while 
particles of 500 nm and above, undergo caveolar endocytic pathways. 37 Therefore, PCL particles 
lyophilized with 1% glucose solution which have more spherical shapes, smaller sizes, improved 
uniformity and smoother surfaces compared to ones lyophilized with 1% PGA solution, contributed to 
better internalization. Knowing that internalized particles have more chances of disrupting the 
 15 
functionality of cells, the explanation of cell viability reduction after exposure of HepG2 cells to 1% 
v/v of PCL particles obtained with 1% glucose is obvious. 
 PCL samples without cryoprotectant at 0.1 and 1 % concentration caused significant increase in 
DCF fluorescence intensity, which was after 5 hour exposure more than two fold higher from that in 
control cells, while sample of PCL with 1% PGA did not significantly alter DCF fluorescence 
intensity (Figure 6). At first glance, time dependent increase in ROS levels are observed in cells by 
PCL particles lyophilized with 1% glucose solution. Negative control also produced a certain amount 
of ROS, suggesting that there was something else in the experiment that gave rise to ROS levels. 
Figure 6 shows that there was no significant increase in DCF fluorescence intensity, apart from 1% 
concentrated sample. The effects of the highest concentrated sample can be explained with increased 
internalization and subsequent harmful interaction of particles with organelles inside the cells. 
 Most cells produce a certain amount of ROS in metabolic processes or as a defence mechanism. 
When that amount is significant, cells are prone to various negative effects such as oxidative stress, 
leading to many diseases. However, link between ROS levels and the induction of toxic effects 
depends on the cell type and is not yet well investigated. 
 
4. Conclusion 
Nanometre scaled spherical PCL particles, with narrow size distribution and with smooth surfaces 
were successful synthesized by physicochemical solvent/non-solvent method and freeze drying 
process. The influence of different cryoprotective excipients (glucose, saccharose, polyvinyl alcohol 
or polyglutamic acid) during freeze drying process was evaluated. Solution of 1% saccharose induced 
crystallisation, while 1% PVA solution formed film, suggesting that at 1% concentration, those 
substances are not always helpful in the preparation of redispersable PCL nanoparticles. When 1% 
PGA solution was added to the formulation, freeze drying produced microspheres with irregularities. 
The best results were achieved using 1% solution of glucose. From size distribution profile, it can be 
seen that 90% of the PCL particles obtained with 1% solution of glucose are less than 960 nm in 
diameter. Biological assays showed improved internalization by liver HepG2 cell line. It can be 
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concluded that physicochemical solvent/non-solvent method, with freeze drying process and 1% 
glucose solution, is a good way of obtaining uniform, but also biocompatible PCL nanospheres for 
biomedical purposes. 
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Figure captions 
Figure 1. FTIR spectra obtained from: a) PCL lyophilized without cryoprotectant; b) PCL lyophilized with 1% saccharose 
solution; c) PCL lyophilized with 1% PGA solution; d) PCL lyophilized with 1% PVA solution and e) PCL lyophilized with 
1% glucose solution. 
Figure 2. Representative SEM images of the samples produced with different cryoprotectants A) PCL without any 
cryoprotectant, B) PCL lyophilized with the addition of 1% saccharose solution, C) PCL with 1% PGA solution, D) PCL 
with 1% PVA solution and E) PCL lyophilized with the addition of 1% glucose solution. 
Figure 3. Representative SEM images of PCL particles dried at room temperature and prepared with the 
addition of 1% glucose solution. The micrographs are given for comparison purposes.  
Figure 4. A) SEM Image: PCL lyophilized with the addition of 1% glucose solution, with marked approximate particle sizes 
and B) DLS size distribution profile: PCL particles lyophilized with 1% glucose solution. 
Figure 5. Viability of HepG2 cells treated with PCL without cryoprotectants (blue), PCL with 1% PGA (green) and PCL 
with 1% glucose (red) for 24 h. The data are presented as mean values of three independent experiments (each with five 
replicates) ± S.D. (*) denotes a significant difference between samples-treated groups and control (Student’s t-test, P<0.05). 
Figure 6. PCL without any cryoprotectant (a), PCL with 1% PGA solution (b) and PCL with 1% glucose solution (c) - 
induced intracellular ROS formation in HepG2 cells. The HepG2 cells were pre-treated with DCFH-DA (20 µM) for 30 min, 
washed and then exposed to different concentrations of PCL (0, 0.001, 0.01, 0.1 and 1 %) or 0.5 mM t-BOOH as the positive 
control (PC). DCF fluorescence intensity was measured at 30 min intervals during the 5 h incubation. (Top) kinetic of ROS 
formation during 5 hour exposure; each point represents the mean of five replicates (±SD) of representative experiment; (*) 
denotes a significant difference between sample-treated groups and control (Student’s t-test, P < 0.05), (Bottom) fold increase 
of ROS level in exposed cells over the level in control cells after 5 hour exposure; each bar represent means (±SD) of three 
independent experiments. (*) denotes a significant difference between sample-treated groups and control (Kruskal - Wallis 
one-way analysis of variance (ANOVA) with Dunett's post test). 
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